Biobeat (Bio‑beat)
Biobeat is a medical‑grade wearable AI platform that continuously measures vital signs and uses predictive analytics to detect patient deterioration early. It supports remote patient monitoring for hospitals, home care, and clinical settings.
Pricing Model: Paid
https://www.bio-beat.com/
Release Date: 11/11/2016

Biobeat (Bio‑beat) Features:

  • Continuous, non‑invasive measurement of multiple vital signs
  • Cuffless blood pressure monitoring via PPG technology
  • Real‑time cloud dashboard for clinicians
  • Early Warning Score (EWS) and predictive deterioration alerts
  • Integration with hospital workflows and EHR systems
  • Wearable wrist and chest patch monitors
  • Historical trend analysis and patient comparisons
  • Customizable alert thresholds per patient
  • FDA 510(k) clearances for multiple parameters
  • CE mark and regulatory compliance for clinical use

Biobeat (Bio‑beat) Description:

Biobeat is an advanced medical‑technology platform combining wearable sensor hardware and AI analytics to deliver continuous patient monitoring in both hospital and home settings. Its core strength lies in integrating physiological signal acquisition with predictive modeling to detect early signs of deterioration, supporting proactive clinical intervention.

The Biobeat system uses proprietary photoplethysmography (PPG) sensors embedded in wrist bands or chest patch monitors to track vital signs non‑invasively. Parameters include cuffless blood pressure, pulse rate, respiratory rate, oxygen saturation, body temperature, stroke volume, cardiac output, and one‑lead ECG (on chest units). The device streams data in real time to a secure, cloud‑based platform. Clinicians access patient dashboards to observe trends, compare historical readings, and receive alerts when values deviate beyond defined thresholds.

A key element is Biobeat’s Early Warning Score (EWS) engine, which applies AI and machine learning to aggregated vital sign data. The system identifies subtle changes in physiology that may signal clinical deterioration, enabling preventive action. Healthcare teams can customize alert rules per patient and scenario. Biobeat also integrates with electronic health records (EHR) systems, streamlining data flow and reducing manual entry.

Biobeat’s wearable devices have secured multiple regulatory clearances. Its platform can monitor a suite of vital metrics with real clinical reliability, making it suitable for hospitals, intensive care, remote patient monitoring, and “hospital‑at‑home” models. The solution supports trend analytics, patient stratification, and remote oversight of high‑risk individuals, especially relevant in post‑discharge care and chronic disease management.

By driving real‑time data to clinical workflows, Biobeat aims to reduce response times, lower costs, and enhance patient outcomes. Its combination of wearables, AI, and cloud infrastructure positions it as a next‑generation remote patient monitoring tool designed for scalability and adoption in modern healthcare systems.

Alternative to Biobeat (Bio‑beat)